Vamil Divan

Stock Analyst at Guggenheim

(4.58)
# 235
Out of 4,910 analysts
238
Total ratings
64.81%
Success rate
15.48%
Average return

Stocks Rated by Vamil Divan

Johnson & Johnson
Jul 17, 2025
Maintains: Neutral
Price Target: $164$167
Current: $169.56
Upside: -1.51%
ProKidney
Jul 14, 2025
Maintains: Buy
Price Target: $6$7
Current: $3.26
Upside: +114.72%
Jade Biosciences
Jun 16, 2025
Upgrades: Buy
Price Target: $14
Current: $8.33
Upside: +68.07%
Savara
May 28, 2025
Maintains: Buy
Price Target: $9$8
Current: $2.55
Upside: +213.73%
Amgen
May 20, 2025
Assumes: Neutral
Price Target: $288
Current: $308.55
Upside: -6.66%
ANI Pharmaceuticals
May 12, 2025
Reiterates: Buy
Price Target: $86
Current: $66.77
Upside: +28.80%
Valneva SE
May 8, 2025
Maintains: Buy
Price Target: $15$14
Current: $7.59
Upside: +84.53%
AbbVie
Apr 29, 2025
Maintains: Buy
Price Target: $214$216
Current: $190.83
Upside: +13.19%
Unicycive Therapeutics
Apr 21, 2025
Initiates: Buy
Price Target: $60
Current: $4.85
Upside: +1,137.11%
Merck & Co.
Apr 17, 2025
Reiterates: Buy
Price Target: $115
Current: $84.11
Upside: +36.73%
Reiterates: Buy
Price Target: $47
Current: $15.96
Upside: +194.49%
Initiates: Buy
Price Target: $31
Current: $18.30
Upside: +69.40%
Reiterates: Buy
Price Target: $10
Current: $3.51
Upside: +184.90%
Reiterates: Buy
Price Target: n/a
Current: $25.35
Upside: -
Maintains: Buy
Price Target: $59$61
Current: $21.88
Upside: +178.79%
Reiterates: Buy
Price Target: $101
Current: $103.52
Upside: -2.43%
Reiterates: Neutral
Price Target: n/a
Current: $14.38
Upside: -
Maintains: Neutral
Price Target: $19$20
Current: $8.76
Upside: +128.31%
Reiterates: Buy
Price Target: $26
Current: $0.67
Upside: +3,808.60%
Maintains: Buy
Price Target: $8$9
Current: $0.74
Upside: +1,119.51%
Initiates: Neutral
Price Target: n/a
Current: $1.78
Upside: -
Maintains: Neutral
Price Target: $27$19
Current: $23.06
Upside: -17.59%
Maintains: Neutral
Price Target: $95$98
Current: $131.64
Upside: -25.55%
Maintains: Buy
Price Target: $36$34
Current: $26.53
Upside: +28.16%
Maintains: Buy
Price Target: $20$10
Current: $1.66
Upside: +502.41%
Maintains: Buy
Price Target: $51$49
Current: $104.97
Upside: -53.32%
Maintains: Buy
Price Target: $315$356
Current: $805.43
Upside: -55.80%
Maintains: Buy
Price Target: $8$6
Current: $5.17
Upside: +16.05%
Maintains: Buy
Price Target: $144$154
Current: $13.69
Upside: +1,024.91%
Upgrades: Buy
Price Target: $15
Current: $9.64
Upside: +55.68%
Downgrades: Neutral
Price Target: n/a
Current: $30.84
Upside: -
Assumes: Neutral
Price Target: n/a
Current: $16.33
Upside: -
Assumes: Outperform
Price Target: $15
Current: $4.75
Upside: +215.79%
Maintains: Neutral
Price Target: $58$61
Current: $48.94
Upside: +24.64%
Initiates: Outperform
Price Target: $103
Current: $1.49
Upside: +6,812.75%